Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

XOMA Royalty Corporation - Common Stock (NQ:XOMA)

41.75 -0.14 (-0.33%)

Streaming Delayed Price Updated: 1:06 PM EDT, May 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	41,967
Open	41.87
Bid (Size)	41.65 (100)
Ask (Size)	41.85 (300)
Prev. Close	41.89
Today's Range	41.67 - 41.99
52wk Range	22.29 - 42.81
Shares Outstanding	11,782,723
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders

May 06, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SLNO, OGN, RMAX, XOMA are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Performance

YTD	+49.2%	+49.2%
1 Month	+13.6%	+13.6%
3 Month	+76.5%	+76.5%
6 Month	+24.7%	+24.7%
1 Year	+68.4%	+68.4%

More News

Halper Sadeh LLC is Investigating Whether XOMA, RMAX, GRTX are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

May 05, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

XOMA Royalty Corporation (NASDAQ:XOMA) Passes Key Growth and Momentum Filters ↗

April 21, 2026

Via Chartmill

XOMA Royalty Corporation (NASDAQ:XOMA) Passes Strict "Little Book" Growth Stock Screen ↗

March 31, 2026

Via Chartmill

XOMA Royalty Corporation (NASDAQ:XOMA) Beats Q4 2025 Earnings Estimates, Stock Rises ↗

March 18, 2026

Via Chartmill

XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm

April 28, 2026

From Schall Law

Via GlobeNewswire

XOMA Royalty Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of XOMA Royalty Corporation - XOMA

April 28, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders

April 27, 2026

From Halper Sadeh LLC

Via GlobeNewswire

April 27, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

XOMA Stock Alert: Halper Sadeh LLC is Investigating Whether XOMA Royalty Corporation is Obtaining a Fair Price for its Shareholders

April 27, 2026

From Halper Sadeh LLC

Via Business Wire

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

April 27, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Declares Quarterly Preferred Stock Dividends

March 18, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead ↗

March 18, 2026

Via Benzinga

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

March 18, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data ↗

March 16, 2026

Via The Motley Fool

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

March 12, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty to Present at Investor Conferences in March

February 18, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

February 09, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

January 20, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

XOMA Royalty Announces CFO Transition

January 12, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

Unusual volume stocks in Wednesday's session ↗

January 07, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

Frequently Asked Questions

Is XOMA Royalty Corporation - Common Stock publicly traded?

Yes, XOMA Royalty Corporation - Common Stock is publicly traded.

What exchange does XOMA Royalty Corporation - Common Stock trade on?

XOMA Royalty Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for XOMA Royalty Corporation - Common Stock?

The ticker symbol for XOMA Royalty Corporation - Common Stock is XOMA on the Nasdaq Stock Market

What is the current price of XOMA Royalty Corporation - Common Stock?

The current price of XOMA Royalty Corporation - Common Stock is 41.75

When was XOMA Royalty Corporation - Common Stock last traded?

The last trade of XOMA Royalty Corporation - Common Stock was at 05/11/26 01:06 PM ET

What is the market capitalization of XOMA Royalty Corporation - Common Stock?

The market capitalization of XOMA Royalty Corporation - Common Stock is 491.93M

How many shares of XOMA Royalty Corporation - Common Stock are outstanding?

XOMA Royalty Corporation - Common Stock has 492M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.